Canada's alliance for excellence in clinical research
From left to right: Thérèse Gagnon-Kugler (Q-CROC), Cynthia Lévesque (CIUSSS de l'Est-de-l'Île-de-Montréal), Hugo Garneau (CHU de Québec...
Sainte-Justine joins the Quebec clinical research network in oncology
Q-CROC is pleased to welcome the CHU Sainte-Justine as the 11th member-institution of its clinical research network in oncology. CHU...
Scientists have identify a DNA signature linked to prostate cancer severity
The Canadian Prostate Cancer Genome Network (CPC-GENE) has published findings from the a comprehensive genetic analysis of prostate...
50th liaison coordinators meeting
From left to right: Solange Tremblay (CISSS de Laval), Anne Brochu (CIUSSS de l'Estrie - CHUS), Claire Gagnon (CISSS du...
Portfolio of clinical trials in oncology in Quebec and databases
Through its role as network coordinator and clinical research development organization, Q-CROC has been able to collect a wide range of...
Clinical Development Success Rates
The Biotechnology Innovation Organization (BIO) has released the largest ever study of clinical development success rates, with a focus...
AstraZeneca launches integrated genomics approach to transform drug discovery and development
AstraZeneca launches integrated genomics approach to transform drug discovery and development. Read the press release:...
In partnership with Q-CROC, Esperas will invest up to $7M in a clinical trial that aims to provide f
MONTREAL, April 11, 2016 /CNW Telbec/ - Esperas Pharma Inc. ("Esperas") today announced the initiation of a project to develop a new oral...
